|
|
||||||||
Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, 197 Ruijin Er Lu, Shanghai 200025, Peoples Republic of China
1 Health Science Center, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences and Shanghai Second Medical University, Shanghai 200025, Peoples Republic of China
(Requests for offprints should be addressed to G Ning; Email: Ningg{at}rjh.com.cn)
The ectopic ACTH syndrome is caused by abnormal expression of the POMC gene product arising from non-pituitary tumors in response to the ectopic activation of the pituitary-specific promoter of this gene. It has been proved that methylation of the CpG island in the promoter region is associated with silencing of some genes. Using bisulphite sequencing, we identified hypermethylation in the 5' promoter region of the POMC gene in three normal thymuses and one large cell lung cancer, and hypomethylation in five thymic carcinoid tumors resected from patients with ectopic ACTH syndrome. The region undergoing hypermethylation was narrowed to coordinates 417 to 260 of the POMC promoter. Furthermore, we observed that the levels of POMC expression correlated with the methylation density at 417 to 260 bp across the E2 transcription factor binding region of the POMC promoter. It is concluded that hypomethylation of the POMC promoter in thymic carcinoids correlates with POMC overexpression and the ectopic ACTH syndrome.
This article has been cited by other articles:
![]() |
D. Rodenhiser and M. Mann Epigenetics and human disease: translating basic biology into clinical applications Can. Med. Assoc. J., January 31, 2006; 174(3): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |